Bile acid metabolism and signaling in liver disease and therapy

Liver Research
John Y L Chiang

Abstract

Bile acids play a critical role in the regulation of glucose, lipid, and energy metabolism through activation of the nuclear bile acid receptor farnesoid X receptor (FXR) and membrane G protein-coupled bile acid receptor-1 (Gpbar-1, aka TGR5). Agonist activation of FXR and TGR5 improves insulin and glucose sensitivity and stimulates energy metabolism to prevent diabetes, obesity, and non-alcoholic fatty liver disease (NAFLD). Bile acids have both pro- and anti-inflammatory actions through FXR and TGR5 in the intestine and liver. In the intestine, bile acids activate FXR and TGR5 to stimulate stimulate fibroblast growth factor 15 and glucagon-like peptide-1 secretion. FXR and TGR5 agonists may have therapeutic potential for treating liver-related metabolic diseases, such as diabetes and NAFLD.

Citations

Mar 20, 2018·Current Opinion in Lipidology·Jan Freark de BoerFolkert Kuipers
May 23, 2018·Antimicrobial Agents and Chemotherapy·Grant NormanValerie L Sim
May 31, 2018·Journal of Applied Toxicology : JAT·Rhishikesh ThakareYazen Alnouti
Jul 6, 2018·American Journal of Physiology. Gastrointestinal and Liver Physiology·Erika TarascoThomas A Lutz
Aug 24, 2018·Clinical Pharmacology and Therapeutics·J Gerry KennaUNKNOWN International Transporter Consortium
Nov 21, 2018·Annals of Clinical Biochemistry·Emma Rose McGlone, Stephen R Bloom
Mar 8, 2019·Current Opinion in Gastroenterology·Vignan Manne, Kris V Kowdley
Apr 16, 2019·Toxicological Sciences : an Official Journal of the Society of Toxicology·Fuhua YangShingo Oda
Feb 27, 2019·Current Pharmaceutical Biotechnology·Isabel Sánchez-CrisóstomoRosa A Bobadilla-Lugo
Aug 15, 2019·Molecular Nutrition & Food Research·Tannaz GhaffarzadeganMargareta Nyman
Jan 28, 2020·American Journal of Physiology. Gastrointestinal and Liver Physiology·John Y L Chiang, Jessica M Ferrell
Jun 19, 2019·Diabetes & Metabolism Journal·Jessica M Ferrell, John Y L Chiang
Jun 6, 2020·The Journal of Infectious Diseases·Susanna NaggieKeyur Patel
Mar 8, 2020·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Francisco J Caballero-CaminoFernando P Cossío
Jun 1, 2018·Canadian Journal of Gastroenterology & Hepatology·Anna CieślakOlivier Barbier
Apr 28, 2019·Nature Reviews. Gastroenterology & Hepatology·Quentin M AnsteeMathias Heikenwalder
Mar 11, 2020·Nature Reviews. Gastroenterology & Hepatology·Judith Aron-WisnewskyKarine Clément
Nov 15, 2019·Scientific Reports·Fatemeh Hassani-Nezhad-GashtiJukka Hakkola
Jan 15, 2019·Journal of Clinical and Translational Hepatology·Yan Li, Lun-Gen Lu
Nov 21, 2018·International Journal of Molecular Sciences·Manon GarciaClaude Beaudoin
Jun 18, 2020·Metabolites·Véronique de BruijnBennard van Ravenzwaay
Apr 7, 2019·Mucosal Immunology·Mei Lan ChenMark S Sundrud
Jul 15, 2020·Metabolites·Sandra SteenselsBaran A Ersoy
Jun 22, 2019·Cellular and Molecular Gastroenterology and Hepatology·Michele BiagioliStefano Fiorucci
Feb 10, 2021·Cellular and Molecular Gastroenterology and Hepatology·Xiao Zhao
Feb 15, 2020·Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids·Christa Buechler, Charalampos Aslanidis
Jan 28, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Hongshan LiYiyang Hu
Feb 23, 2021·Health Science Reports·Marianne GagnonAnne-Sophie Morisset
Mar 27, 2018·Liver Research·Yulan ZhaoLi Wang
Apr 2, 2019·Journal of Hepatology·Atish MukherjiThomas F Baumert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.